NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD
  • XY Feed
  • 24-HOUR Pass ↗
  • Push Notifications
Sign in Subscribe

Mission Produce Beats Q3 Estimates, Raises Calavo Savings Outlook to Over $30 Million

Fiscal Q3 showed $450 million in sales and $32.4 million adjusted EBITDA.

Mission Produce Beats Q3 Estimates, Raises Calavo Savings Outlook to Over $30 Million
Photo by John Vid on Unsplash
Already have an account? Sign in.
09/09/2026 · 5:42 AM
AVO
/ Don’t stop at just one post.

Related↓

Mission Produce to Acquire Calavo Growers in Major Avocado Industry Deal
Featured/ 01/14/2026 · 4:34 PM

Mission Produce to Acquire Calavo Growers in Major Avocado Industry Deal

Mission Produce announces $430M acquisition of Calavo Growers, creating a larger avocado and fresh produce platform with expanded offerings including guacamole and prepared foods.

/ Subscriber only
/ Read more

Feed↓

Instacart in Preliminary Talks for Potential Sale, DoorDash and Uber Involved
Featured/ 10/23/2026 · 4:22 PM

Instacart in Preliminary Talks for Potential Sale, DoorDash and Uber Involved

Instacart is exploring a sale that could value the company at $16–17 billion, with preliminary talks involving DoorDash and Uber.

/ Subscriber only
Scotiabank Sees Bargain in AST SpaceMobile After 70% Drop, Upgrades Stock
Featured/ 10/23/2026 · 3:41 PM

Scotiabank Sees Bargain in AST SpaceMobile After 70% Drop, Upgrades Stock

Analysts upgrade AST SpaceMobile to Outperform after a sharp drop. Scotiabank cites SpaceX competition but sees value in AST’s wholesale 5G model.

/ Subscriber only
Corcept Faces New Competitive Pressure as Genmab’s Rina-S Shows Broad Benefit in Platinum-Resistant Ovarian Cancer
10/23/2026 · 2:44 PM

Corcept Faces New Competitive Pressure as Genmab’s Rina-S Shows Broad Benefit in Platinum-Resistant Ovarian Cancer

Rina-S shows significant PFS and OS gains in platinum-resistant ovarian cancer, challenging Corcept’s Lifyorli position.

/ Subscriber only
Explore
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD
  • XY Feed
  • 24-HOUR Pass ↗
  • Push Notifications
More
  • Sign up
  • Sign in
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Terms/Privacy
  • UP↑
Get alerts

Be the first to know when deals break, stocks move, or biotech headlines hit.

Email address Subscribe
DON'T FALL BEHIND. ©2026
For informational purposes only. Not financial advice.
NOTRELOAD AI